Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
Gilberto de Castro, Iveta Kudaba, Yi-Long Lung Cancer Wu, Gilberto De Lima Lopes Jr., Dariusz Mirosław Kowalski, H.Z. Turna and 12 more
- Rank
- 31 of 548
- Percentile
- top 5.7%
- Where
- Journal of Clinical Oncology, 2022
- Citations
- 332
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.